These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 9766719
21. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T, Endo K. Cancer; 2002 Feb 15; 94(4):921-8. PubMed ID: 11920459 [Abstract] [Full Text] [Related]
22. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, De Wever W, Coosemans W, Decker G, De Leyn P, Deneffe G, Van Raemdonck D, Mortelmans L. Ann Surg; 2000 Dec 15; 232(6):743-52. PubMed ID: 11088069 [Abstract] [Full Text] [Related]
23. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer? Torrance AD, Almond LM, Fry J, Wadley MS, Lyburn ID. Surgeon; 2015 Feb 15; 13(1):19-33. PubMed ID: 24206935 [Abstract] [Full Text] [Related]
27. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma. Chowdhury FU, Bradley KM, Gleeson FV. Clin Radiol; 2008 Dec 15; 63(12):1297-309. PubMed ID: 18996259 [Abstract] [Full Text] [Related]
30. Motion-compensated FDG PET/CT for oesophageal cancer. Voncken FEM, Vegt E, van Sandick JW, van Dieren JM, Grootscholten C, Bartels-Rutten A, Takken SL, Sonke JJ, van de Kamer JB, Aleman BMP. Strahlenther Onkol; 2021 Sep 15; 197(9):791-801. PubMed ID: 33825916 [Abstract] [Full Text] [Related]
31. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, Xu G, Yang W, Zhao S. Dis Esophagus; 2012 Jul 15; 25(5):416-26. PubMed ID: 21951837 [Abstract] [Full Text] [Related]
32. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Ann Thorac Surg; 2001 Jan 15; 71(1):290-4. PubMed ID: 11216764 [Abstract] [Full Text] [Related]
33. Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer. Gillies RS, Middleton MR, Maynard ND, Bradley KM, Gleeson FV. Eur Radiol; 2011 Feb 15; 21(2):274-80. PubMed ID: 20821013 [Abstract] [Full Text] [Related]
37. Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in oesophageal cancer. Schreurs LM, Pultrum BB, Koopmans KP, Verhoef CC, Jager PL, Van Dam GM, Groen H, Van Der Jagt EJ, Plukker JT. Anticancer Res; 2008 Feb 15; 28(3B):1867-73. PubMed ID: 18630473 [Abstract] [Full Text] [Related]
40. PET/CT: will it change the way that we use CT in cancer imaging? Hicks RJ, Ware RE, Lau EW. Cancer Imaging; 2006 Oct 31; 6(Spec No A):S52-62. PubMed ID: 17114079 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]